XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Operating activities      
Net income (loss) $ (155,891) $ 679,465 [1]  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Interest sensitive and index product benefits 57,911 287,917 [2]  
Amortization of deferred sales inducements 46,601 45,085 [1]  
Annuity product charges (62,591) (52,355) [2]  
Change in fair value of embedded derivatives 404,440 (1,393,649) [2]  
Change in traditional life and accident and health insurance reserves 1,720 (30,313) [2]  
Policy acquisition costs deferred (66,767) (56,897) [2]  
Amortization of deferred policy acquisition costs 68,235 72,969 [2]  
Provision for depreciation and other amortization 3,025 2,250 [2]  
Amortization of discounts and premiums on investments 13,450 (258) [2]  
Realized gains/losses on investments 27,787 13,127 [1]  
Change in fair value of derivatives (45,890) 477,519 [2]  
Deferred income taxes (40,895) 184,840 [2]  
Share-based compensation 9,904 5,596 [2]  
Change in accrued investment income 426 (38,805) [2]  
Change in income taxes recoverable/payable 4,677 519 [2]  
Change in other assets (34,940) (11,927) [2]  
Change in other policy funds and contract claims (207,895) 197,191 [2]  
Change in market risk benefits, net 192,253 197,617 [2]  
Change in collateral held for derivatives 184,088 (584,969) [2]  
Change in funds withheld from reinsurers 342,602 80,767 [2]  
Change in other liabilities 145,648 86,008 [2]  
Other (22,855) (61,765) [2]  
Net cash provided by operating activities 865,043 99,932 [2]  
Sales, maturities, or repayments of investments:      
Fixed maturity securities, available for sale 3,150,639 1,779,328 [2]  
Mortgage loans on real estate 279,348 536,216 [2]  
Derivative instruments (132) 280,510 [2]  
Other investments 705,059 26,376 [2]  
Acquisitions of investments:      
Fixed maturity securities, available for sale (2,039,525) (3,924,643) [2]  
Mortgage loans on real estate (534,632) (585,867) [2]  
Real estate investments acquired (120,907) (168,088) [2]  
Derivative instruments (205,561) (185,486) [2]  
Other investments (425,596) (202,160) [2]  
Purchases of property, furniture and equipment (4,192) (2,424) [2]  
Net cash provided by (used in) investing activities 804,501 (2,446,238) [2]  
Financing activities      
Receipts credited to annuity policyholder account balances 1,370,663 888,488 [2]  
Coinsurance deposits (215,927) 10,757 [2]  
Return of annuity policyholder account balances (1,601,547) (1,198,638) [2]  
Repayment of loan payable (1,875) 0 [2]  
Acquisition of treasury stock (293,193) (179,396) [2]  
Proceeds from issuance of common stock, net (3,631) 251,538 [2]  
Change in checks in excess of cash balance (54,932) 9,393 [2]  
Dividends paid on preferred stock (10,919) (10,919) [2]  
Net cash provided used in financing activities (811,361) (228,777) [2]  
Increase (decrease) in cash and cash equivalents 858,183 (2,575,083) [2]  
Cash and cash equivalents at beginning of period 1,919,669 4,508,982 [2] $ 4,508,982 [2]
Cash and cash equivalents at end of period 2,777,852 1,933,899 [2] $ 1,919,669
Cash paid during period for:      
Interest expense 5,803 1,250 [2]  
Income taxes 262,020 0 [2]  
Income tax refunds received 52,500 0 [2]  
Non-cash operating activity:      
Deferral of sales inducements $ 45,267 $ 23,446 [2]  
[1] Certain prior period amounts have been recast. See Note 1 - Significant Accounting Policies for more information.
[2] Certain prior period amounts have been recast. See Note 1 - Significant Accounting Policies for more information.